For the treatment of obsessive-compulsive disorder the new drug is fully developed by Exscientia Artificial Intelligence at Oxford. The drug is already preparing for testing in humans.

Scientists from the University of California have carried out the first clinical trial of a cure for stuttering. Only 9 patients took part in the test, however, almost all subjects had improved their speech.

The new scanner uses a 130 tons super magnet with the help of which doctors hope to get the opportunity for early diagnosis of many brain diseases.

A new clinical practice guideline by the International Society for Dietary Psychiatry Research recommends omega-3 polyunsaturated fatty acids as an adjunctive therapy for major depressive disorder.

Swiss scientists have determined that a period of 30 to 32 years is the perfect age for treating multiple sclerosis. If you delay the start of treatment for multiple sclerosis up to 40 years, then the risk of disability increases significantly.

The Nobel Prize was awarded by U.S. scientists William Kelin and Gregg Semence, as well as their British counterpart Peter Ratcliff in 2019. They received the Nobel Prize in Physiology or Medicine due to their discovery in the field of cancer therapy.

Metformin has shown astounding results in an animal clinical study. The study has established the ability of metformin to influence on the recovery of the myelin sheath in rats. Next year, scientists are going to carry out the research on humans.

Thanks to CRISPR/Cas9 gene editing technology, scientists were able to significantly suppress the activity of three types of herpes in the human body and achieve 95% virus reduction in the cells!

A cream based on ruxolitinib (a selective inhibitor of Janus kinases) has shown excellent results in patients with vitiligo. The cream significantly improved whole body repigmentation for 52 weeks.

The FDA has approved the first contact lenses indicated to slow myopia in children aged 8 to 12 years.